Sign in
RIP 2 FAF
Roberto Gallego-Pinazo, MD, PhD, DiSSO
Retina Image Bank: Images of the Week
2015
Baseline Factors Associated With 1-Year Outcomes in Phase III Comparison of SB11 (Approved Ranibizumab Biosimilar) With Reference Ranibizumab in nAMD
Neil M. Bressler, MD
Annual Meeting Talks
2022
Episode 119: 2018 ASRS Annual Meeting Post-Mortem Including Protocol S 5-Year Results
Jayanth Sridhar, MD
Member Podcasts
2018
Category: AMD-Non-Neovascular